Clinical

Dataset Information

0

Clinical trial on the efficacy of the UFT/LV for the Stage II colorectal cancer with risk factors for recurrence


ABSTRACT: Interventions: UFT/LV as postoperative adjuvant chemotherapy for the stage II colorectal cancer is tested as follows: one patient group for 28 days with 7 days rest (everyday medication) and another patient group for 5days with 2days rest (5-days on/2-days, Saturday and Sunday, off). Both medications are conducted for 25weeks as 5 courses (1 course=5weeks, 35days) from the date of the start of the therapy. After the treatment, both patient groups are simply observed without any more therapy, unless any recurrent lesions or any other cancer lesions are observed in them. The surgery alone group is simply observed without therapy, unless any recurrent lesions or any other cancer lesions (synchronous cancers or multiple colorectal cancers) are observed in them. Primary outcome(s): Disease-free survival Study Design: Parallel Randomized

DISEASE(S): Stageii Colorectal Cancer

PROVIDER: 2623196 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2614017 | ecrin-mdr-crc
| 2628537 | ecrin-mdr-crc
2013-01-03 | E-GEOD-19860 | biostudies-arrayexpress
2011-03-15 | E-GEOD-23946 | biostudies-arrayexpress
2021-04-01 | GSE128213 | GEO
2008-10-01 | GSE12794 | GEO
2022-07-01 | GSE206225 | GEO
2021-08-10 | PXD026819 | Pride
2012-07-16 | E-GEOD-39387 | biostudies-arrayexpress
2018-11-15 | GSE75017 | GEO